Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M148Revenue $M0.2Net Margin (%)0Z-Score2.2
Enterprise Value $M67.6EPS $-0.6Operating Margin %0F-Score3
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)0Higher ROA y-yN
Price/Book1.310-y EBITDA Growth Rate %0Quick Ratio17.4Cash flow > EarningsY
Price/Sales05-y EBITDA Growth Rate %-24.6Current Ratio17.4Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-34.1Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)2ROE % (ttm)-37.6Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M91.6ROI % (ttm)0Gross Margin Increase y-yN

Gurus Latest Trades with ONTY

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ONTYJean-Marie Eveillard 2014-09-30 Sold Out -0.02%$2 - $3.29
($2.54)
$ 1.62-36%Sold Out0
ONTYGeorge Soros 2014-06-30 Sold Out $2.35 - $3.5
($2.94)
$ 1.62-45%Sold Out0
ONTYGeorge Soros 2014-03-31 Buy $1.71 - $3.89
($2.7)
$ 1.62-40%New holding, 89600 sh.89,600
ONTYJean-Marie Eveillard 2013-09-30 Add0.01%$1.59 - $2.18
($1.75)
$ 1.62-7%Add 75.63%2,275,287
ONTYJean-Marie Eveillard 2013-06-30 Add0.01%$1.57 - $2.63
($2.14)
$ 1.62-24%Add 547.75%1,295,499
ONTYAndreas Halvorsen 2013-06-30 Sold Out -0.05%$1.57 - $2.63
($2.14)
$ 1.62-24%Sold Out0
ONTYJean-Marie Eveillard 2013-03-31 Buy $1.86 - $2.35
($2.09)
$ 1.62-22%New holding, 200000 sh.200,000
ONTYJean-Marie Eveillard 2012-03-31 Sold Out -0.0033%$4.16 - $8.96
($6.31)
$ 1.62-74%Sold Out0
ONTYJean-Marie Eveillard 2011-12-31 Add$5.84 - $8.25
($6.85)
$ 1.62-76%Add 33.33%100,000
ONTYAndreas Halvorsen 2011-09-30 Buy 0.22%$5.95 - $10.2
($7.49)
$ 1.62-78%New holding, 3110650 sh.3,110,650
ONTYJean-Marie Eveillard 2011-09-30 Reduce-0.01%$5.95 - $10.2
($7.49)
$ 1.62-78%Reduce -66.67%75,000
ONTYJean-Marie Eveillard 2011-06-30 Buy 0.01%$3.8 - $9.43
($5.79)
$ 1.62-72%New holding, 225000 sh.225,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ONTY is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
ONTY Jean-Marie Eveillard 2014-09-30000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


ONTY: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BVF PARTNERS L P/IL10% Owner 2014-12-17Buy378,444$1.82-10.99view
BVF PARTNERS L P/IL10% Owner 2014-12-12Sell0$0-10.99view
Venkatesan JayEVP and General Manager 2014-09-23Buy250,000$2-19view
BVF PARTNERS L P/IL10% Owner 2013-11-01Buy129,000$1.78-8.99view
BVF PARTNERS L P/IL10% Owner 2013-08-08Buy258,361$1.65-1.82view
BVF PARTNERS L P/IL10% Owner 2013-08-01Buy338,087$1.74-6.9view
SPIEGELMAN DANIEL KDirector 2013-07-10Sell16,183$1.91-15.18view
BVF PARTNERS L P/IL10% Owner 2013-06-07Buy214,467$1.81-10.5view
Ayer Capital Management, LP10% Owner 2011-06-23Sell28,900$8.74-81.46view
Karan Shashi K.Corporate Controller 2010-09-28Buy5,100$3.41-52.49view

Press Releases about ONTY :

    Quarterly/Annual Reports about ONTY:

    News about Onty:

    Articles On GuruFocus.com
    Value Betting with Special Situations: Lessons from the World of Gambling Mar 05 2013 
    pro-longs life Jul 30 2011 
    Cubist Pharmaceutical - Acutely Aware May 09 2010 
    Cubist Pharmaceutical - Acutely Aware May 09 2010 
    cooldecency99 note on ONTY May 01 2010 
    creiter note on ONTY Jan 03 2010 

    More From Other Websites
    ONCOTHYREON INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements... Jan 08 2015
    ONCOTHYREON INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a... Dec 12 2014
    Oncothyreon Announces Presentation of Positive ONT-380 Data at San Antonio Breast Cancer Symposium Dec 12 2014
    Oncothyreon Announces Exclusive License Agreement With Array BioPharma for ONT-380 Dec 12 2014
    Oncothyreon Announces Presentation of Positive ONT-380 Data at San Antonio Breast Cancer Symposium Dec 12 2014
    Oncothyreon Announces Exclusive License Agreement With Array BioPharma for ONT-380 Dec 12 2014
    Oncothyreon Inc. (ONTY) in Focus: Stock Surges 10.1% Nov 28 2014
    ONCOTHYREON INC. Financials Nov 14 2014
    Oncothyreon to Present at Stifel 2014 Healthcare Conference Nov 12 2014
    Oncothyreon and Celldex Therapeutics Announce Initiation of Combination Immunotherapy Clinical Trial... Nov 10 2014
    Oncothyreon and Celldex Therapeutics Announce Initiation of Combination Immunotherapy Clinical Trial... Nov 10 2014
    10-Q for Oncothyreon, Inc. Nov 08 2014
    Oncothyreon posts 3Q loss Nov 06 2014
    Oncothyreon posts 3Q loss Nov 06 2014
    ONCOTHYREON INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Nov 06 2014
    Oncothyreon Reports Third Quarter 2014 Financial Results Nov 06 2014
    Oncothyreon Announces Third Quarter 2014 Financial Results Conference Call Oct 30 2014
    Oncothyreon Announces Third Quarter 2014 Financial Results Conference Call Oct 30 2014
    ONCOTHYREON INC. Files SEC form 8-K/A, Financial Statements and Exhibits Oct 22 2014
    UPDATE: H.C. Wainwright & Co. Initiates Coverage On Oncothyreon On Significant Upside Oct 21 2014
    Alexion Pharmaceuticals (ALXN) in Focus: Stock Rises 6.0% Oct 06 2014
    ONCOTHYREON INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year Sep 23 2014
    ONCOTHYREON INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events Sep 18 2014
    Oncothyreon Prices $40 Million Concurrent Public Offerings of Common Stock and Preferred Stock Sep 18 2014
    Oncothyreon Announces Proposed Public Offerings Sep 17 2014
    Will Oncothyreon (ONTY) Crush Estimates at Its Next Earnings Report? Sep 16 2014
    ONCOTHYREON INC. Files SEC form 8-K, Other Events Sep 12 2014
    Oncothyreon Announces First Quarter 2014 Financial Results Conference Call Apr 24 2014
    Oncothyreon Reports Full Year and Fourth Quarter 2013 Financial Results Mar 13 2014
    Oncothyreon Announces Full Year and Fourth Quarter 2013 Financial Results Conference Call Mar 06 2014
    Oncothyreon to Present at Cowen and Company 34th Annual Health Care Conference Feb 26 2014
    Oncothyreon and Array BioPharma Announce Initiation of Phase 1b Trial of ONT-380 in Combination with... Feb 20 2014
    Oncothyreon and Array BioPharma Announce Initiation of Phase 1b Trial of ONT-380 in Combination with... Feb 03 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK